Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts.

Carlos MachahuaSabina A GulerMichael P HornLurdes Planas-CerezalesAna Montes-WorboysThomas K GeiserMaria Molina-MolinaManuela Funke-Chambour

Published in: BMJ open respiratory research (2021)

Serum calprotectin levels are significantly increased in patients with IPF compared with healthy controls and correlate with DLCO and CPI. Calprotectin might be a potential new biomarker for disease severity in IPF.

Keyphrases

idiopathic pulmonary fibrosis
disease activity
interstitial lung disease
physical activity
systemic lupus erythematosus
risk factors